February 13, 2024
A pilot project by the CHUM and Pharmaprix is hoping to offer some 100 women greater care post-birth, particularly when it comes to cardiovascular risks. Complications such as gestational hypertension, gestational diabetes and pre-eclampsia are followed during pregnancy but can also translate into a higher risk of cardiovascular disease if not monitored after birth. Participants in the study will receive local care through access to a pharmacist and a specialized NP. As a first step, the pilot project will assess how many participants attend their pharmacy appointments. The project could be expanded to measure clinical outcomes, such as fewer instances of poorly controlled hypertension or cardiovascular complications.